Product information

Current status:

Cancelled Post Market

Current status date:

2001-04-05

Original market date: ^{See footnote 1}

1992-12-31

Product name:

METANDREN 25MG

DIN:

00005630 Electronic product monograph is not available

Company:

NOVARTIS PHARMACEUTICALS CANADA INC
100 700 Rue Saint-Hubert
Montreal
Quebec
Canada H2Y 0C1

Class:

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Schedule G (CDSA IV)

American Hospital Formulary Service (AHFS): ^{See footnote 3}

68:08.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

G03BA02 METHYLTESTOSTERONE

Active ingredient group (AIG) number:^{See footnote5}

0106376002